Use of catecholamine reuptake inhibitors to enhance memory
OwnerMel Epstein, Kjesten A. Wiiginventors
Life of this patent
Estimating the term…
Abstract
The present invention makes available methods and reagents for enhancing memory, e.g., to increase memory function such as long-term memory and recall ability.
Claims33
A method for enhancing long term memory in an animal, comprising administering to the animal a formulation of a catecholamine reuptake inhibitor in an amount sufficient to enhance long-term memory in the animal.
A medicament for enhancing memory in an animal, comprising a formulation of a catecholamine reuptake inhibitor in an amount sufficient to enhance long-term memory in the animal.
A method for preparing a formulation for enhancing memory consolidation in an animal, comprising preparing a pharmaceutical preparation comprising one or more catecholamine reuptake inhibitors in an amount sufficient to enhance long-term memory in the animal.
24 The medicament of claim 22, or the method of claim 23, wherein the catecholamine reuptake inhibitor is a norepinephrine reuptake inhibitor.
A kit comprising one or more catecholamine reuptake inhibitors, provided in single oral dosage form or as a transdermal patch, in an amount sufficient for enhancing memory in a patient, and in association with instructions (written and/or pictorial) describing the use of the kit for enhancing memory, and optionally, warnings of possible side effects and drug-drug or drug-food interactions.
A method for conducting a pharmaceutical business, comprising:
- a. determining an appropriate dosage of a catecholamine reuptake inhibitor(s) to enhance memory function in a class of patients;
- b. conducting therapeutic profiling of one or more formulations of the catecholamine reuptake inhibitor(s) identified in step (a), for efficacy and toxicity in animals;
- and
- c. providing a distribution network for selling a the formulations identified in step (b) as having an acceptable therapeutic profile.
A method for conducting a pharmaceutical business, comprising:
- a. determining an appropriate dosage of a catecholamine reuptake inhibitor to enhance memory function in a class of patients;
- and
- b. licensing, to a third party, the rights for further development and sale of the catecholamine reuptake inhibitor for enhancing memory.
Dependencies are inferred from the claim text.